跳至主要内容
临床试验/ACTRN12620000263998
ACTRN12620000263998已完成未知

Distinguishing Gastroesophageal Reflux Disease and Eosinophilic Esophagitis in Adults: the Role Esopahegal Mucosal Immunoglobulin IG4

GI and Pancreatic Researchs Group0 个研究点目标入组 60 人开始时间: 2020年2月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • -18-80 years of age
  • -typical symptoms of GERD responsive to PPI therapy
  • -evidence of oesophagitis on endoscopy with supportive oesophageal biopsy specimens --eosinophil count <10/hpf
  • -18-80 years of age, symptoms of oesophageal dysfunction with 'greater than or equal to' 15 eosinophils/hpf
  • -exclusion of other causes of eosinophilia

排除标准

  • Exclusion criteria were history of severe respiratory, cardiovascular, hepatic, haematological and/or renal disease, chronic alcohol abuse, medications that may influence gastrointestinal function and previous gastrointestinal surgery.

研究者

发起方
GI and Pancreatic Researchs Group

相似试验